Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (2)

June 27, 2005
Keiji Nakamura, Ph. D. Pharma-Forum Institute, Kamakura, Japan Therapeutic benefits of glitazones - pioglitazone and rosiglitazone PPAR-g is a ligand-activated transcription factor belonging to the nuclear hormone receptor superfamily. PPAR-g regulates gene expression by forming a heterodimer with the retinoid...read more